SOUTHLAKE, Texas, Sept. 24, 2026 /PRNewswire/ -- Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio, renal and metabolic diseases, today announced its participation in the Oppenheimer Private Life Sciences Showcase, taking place virtually…